シッカ症候群(シェーグレン)治療薬の世界市場:治験レビュー

◆英語タイトル:Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2019
◆商品コード:GDT20FB0045
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:170
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2019″ provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical trials on Sicca Syndrome (Sjogren) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Sicca Syndrome (Sjogren) Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Sicca Syndrome (Sjogren) 33
Nov 12, 2019: Alpine Immune Sciences presents new ALPN-101 preclinical data at the 2019 American College of Rheumatology (ACR) Annual Meeting 33
Nov 11, 2019: Encouraging Phase 2 data on cenerimod – Idorsia’s S1P1 receptor modulator currently investigated for SLE – presented at ACR 2019 33
Oct 02, 2019: Alpine Immune Sciences announces upcoming scientific presentation of ALPN-101 at ACR/ARHP 2019 Annual Meeting 34
Oct 02, 2019: Data on cenerimod – Idorsia’s S1P1 receptor modulator – will be presented at the ACR / ARP Annual Meeting 2019 34
Clinical Trial Profile Snapshots 36
Appendix 172
Abbreviations 172
Definitions 172
Research Methodology 173
Secondary Research 173
About GlobalData 174
Contact Us 174
Source 175

List of Tables
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region, 2019* 8
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase, 2019* 23
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32

List of Figures
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 23
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 24
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 28
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
GlobalData Methodology 173

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[シッカ症候群(シェーグレン)治療薬の世界市場:治験レビュー]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆